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In the United States alone, more than 65,000 patients are on the waiting list for kidney transplantation. Concerted efforts have been made to increase cadaver and live organ 
donation, but these initiatives have not been 
sufficient to meet the demand spurred by the 
remarkable success of transplantation programs. 
It has been estimated that the shortage of avail-
able kidneys is largely responsible for the death 
of 3000 patients on the United States waiting 
list every year.1 Supported by this reality, a sig-
nificant organ market has developed; the World 
Health Organization estimates that 5%–10% of 
the nearly 70,000 kidneys transplanted annually 
are obtained by organ trafficking.2 China, India, 
Pakistan, Egypt, Brazil, the Philippines, Molda-
via, Romania, and Colombia are recognized ‘hot 
spots’ for organ trafficking.3
The ethical problems derived from the sell-
ing of parts of the human body and the need to 
address the problem of the shortage of organs 
have been the subject of many meetings, sym-
posia, debates, and publications. Most notable 
among previous meetings was that of a task force 
organized in 1997 by Columbia University that 
produced a widely publicized report addressing 
the issues of body integrity and the sale of organs, 
the use of organs from executed prisoners, and 
allegations of kidnapping and murder for organ 
procurement.4 The recent Declaration of Istan-
bul,5 published in this issue of Kidney Interna-
tional, is an important result of the meeting of 
152 participants from 78 countries, convened 
by the Transplantation Society and the Interna-
tional Society of Nephrology in response to the 
alarming rates of organ trafficking and transplant 
tourism. This is a landmark position paper that 
should be examined in the context of the contro-
versial issue of the remuneration of organ donors 
and the potential impact that this Declaration 
could have in halting unacceptable practices in 
human transplantation.
The ethical boundaries of financial compensa-
tion for organ donors have long been a matter of 
dispute. While it is repugnant to see parts of the 
human body treated as commodities, there is a 
wide range of commercialism in transplantation 
(compensation for expenses is not considered 
commercialism), from subtle financial rewards 
to the relatives of a cadaver donor to cover burial 
costs to the criminal exploitation of the poor in 
the purchase of their kidneys for the rich. The 
unmovable ethical stand that parting with any 
parcel of the body for monetary gain violates the 
dignity of the human person6 is not shared by 
many1,4,7–9 and, like other moral issues in the 
field of transplantation that once appeared to be 
written in stone, may change over time as novel 
medical treatments and new facts become avail-
able. Such has been the case with the Catholic 
perspective on live organ donation: Pope Pius XI 
advised against it in 1930 in his encyclical let-
ter Casti Connubi, whereas in 1980 Pope John 
Paul II defined donation as “an act of supreme 
charity.”10 Authoritative voices have expressed a 
positive opinion about payments, financial com-
pensation,1,8,9 or other incentives11 as means of 
increasing organ donation, and the Bellagio Task 
Force report stated categorically that that there 
is “no unarguable ethical principle that would 
justify a ban on the sale of organs under all cir-
cumstances” but, nevertheless, proposed that 
prohibition of the sale of solid organs from live 
unrelated donors should be continued.4
Setting aside the ethical issues that may 
accompany the assignation of financial rewards 
for organ donation, the crude reality is that in 
the vast majority of the cases it is the socio-
economic situation of the very poor that leads 
to the exchange of a kidney for a payment that 
may range from US$1000 to $5000, while the 
brokers charge the wealthy transplant recipients 
$100,000 to $200,000.12 A particular example of 
the success of the kidney trade are ‘kidney colo-
nies,’ such as the one in the Tamil Nadu, where 
poverty is extreme and kidneys are considered 
a financial reserve. In this Indian state near 
Madras, over 5000 people have donated their 
kidneys for financial gain, and in a population 
survey, one or more occupants in 10% of the 
households have donated a kidney.4 It should 
be noted that the financial gain obtained by 
donating a kidney does not lead to long-term 
economic benefit for the donor. Goyal et al.13 
reported that 6 years after donation, the per-
centage of paid donors below the poverty line 
increased from 54% to 71%, and 86% reported 
deterioration in their health status. Interestingly, 
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the notion that the underprivileged may serve 
as organ donors is not new. An iconic medieval 
painting by Fernando del Rincón, represent-
ing the immediate postoperative period of the 
miraculous surgery performed by the physician 
saints Cosme and Damian in ad 300, portrayed 
an apparently solvent church member with a 
transplanted leg taken from a black servant (pre-
sumably dead). Remarkably, the healthy leg of 
the donor that was removed for transplantation 
was replaced by the gangrenous leg that afflicted 
the church member.
Compelling arguments have been raised that 
the best strategy to halt a commercial system of 
procurement driven by organ shortage, often per-
formed in backstreet clinics by unscrupulous doc-
tors, is the establishment of a government-regulated 
program that would include a fixed financial reward 
for the donor and be centered on a transparent 
organ allocation strategy in which no role is played 
by the personal wealth of the recipient.1,8,9 In fact, 
such a system is operating in Iran and has accom-
plished the elimination of an organ waiting list and 
a fair distribution of organs made available by vol-
untary unrelated donors.7,14,15 Without entering 
the debate of the relative value of these proposals, 
it is unlikely that they may be applicable worldwide. 
At least in my opinion, the establishment of a gov-
ernment-sponsored system of financially rewarded 
organ donation from living unrelated donors would 
lead to even more abuses of the people who live in 
extreme poverty in countries where abject poverty 
is frequent and corruption commonplace. The Dec-
laration of Istanbul5 stands unequivocally against 
the exploitation of the desperate living conditions 
of the poor, emphasizes the need for informed 
consent, demands extended health care of donors 
and recipients, and calls for transparent regulatory 
oversight with international accountability.
Is the Declaration of Istanbul5 likely to make a 
dent in organ trafficking and transplant tourism? 
Probably not in the short run, since the imbalance 
between organ need and organ availability, the 
socioeconomic gap between the rich and the poor, 
and the dark side of human nature are with us for 
the long haul. However, it may increase the resolve 
of governments, medical associations, and society 
in general to act against the use of the world’s poor 
as a source of organs for the rich.
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